by De Rubeis G, Napp AE, Schlattmann P, Geleijns J, Laule M, Dreger H, Kofoed K, Sørgaard M, Engstrøm T, Tilsted HH, Boi A, Porcu M, Cossa S, Rodríguez-Palomares JF, Xavier Valente F, Roque A, Feuchtner G, Plank F, Štěchovský C, Woinke M, Károlyi M, Karády J, Donnelly P, Ball P, Dodd J, Hensey M, Mancone M, Ceccacci A, Berzina M, Zvaigzne L, Sakalyte G, Basevičius A, Ilnicka-Suckiel M, Kuśmierz D, Faria R, Gama-Ribeiro V, Benedek I, Benedek T, Adjić F, Čanković M, Berry C, Delles C, Thwaite E, Davis G, Knuuti J, Pietilä M, Kepka C, Kruk M, Vidakovic R, Neskovic AN, Lecumberri I, Diez Gonzales I, Ruzsics B, Fisher M, Dewey M, Francone M, DISCHARGE Trial Group[Corporate Author]
30(4):1997‐2009. FI 3,962